Processamento e caracterização de creme de queijo coalho com óleo de peixe / Processing and characterization of coalho cheese cream with fish oil

O óleo de peixe é fonte de ômega 3, que atua no combate, prevenção e/ou tratamento de doenças crônicas. O queijo coalho é bastante consumido no Nordeste brasileiro, e na forma de creme adicionado de óleo de peixe torna-se uma nova alternativa para o consumidor. Assim, objetivou-se desenvolver e avaliar formulações de creme de queijo coalho (CQQ) com orégano, com ou sem óleo de peixe. Inicialmente, foi realizada uma pesquisa com 70 consumidores de queijo, seguida da elaboração de três formulações de CQQ (F1: sem óleo de peixe; F2: com 0,54g óleo de peixe; F3: com 1,08g de óleo de peixe). Obtidos os CQQs, as formulações (F1, F2 e F3) foram avaliadas no que se refere a: fungos, coliformes totais e termotolerantes, estafilococus coagulase positiva e Salmonella sp; aceitação e preferência sensorial; composição centesimal, fenólicos totais, atividade antioxidante, pH, acidez total titulável e valor calórico. O sabor foi o fator mais importante na escolha de um produto, sendo o ômega 3 (54,28%) e o orégano (57,14%) escolhidos pela maioria dos entrevistados. Todas as formulações estavam seguras microbiologicamente e apresentaram a mesma aceitabilidade e preferência sensorial. A aceitabilidade variou entre 7,43 a 8,13. As formulações de CQQ são de acordo com a legislação, desnatadas (1,77 a 2,66% de lipídios), têm muito alta umidade (≥55%) e baixa acidez (3,12 a 3,28g ácido lácteo/100g), e apresentaram expressiva atividade antioxidante e potencial para comercialização (índice de aceitação ≥70%). Os CQQs são viáveis para incorporação de óleo de peixe, sendo um produto fonte de ômega 3 e que pode apresentar propriedade funcional. (AU)

Fish oil is a source of omega 3 that acts in the fight, prevention and/or treatment of chronic diseases. Coalho cheese is largely consumed in the Northeastern Brazil, and in the form of cream added with fish oil it becomes a new alternative to consumers. Thus, the aim of this study was to develop and assess coalho cheese cream (CCC) formulations added with oregano, with or without fish oil. Firstly, a survey was conducted with 70 cheese consumers, followed by the preparation of three CCC formulations (F1: without fish oil; F2: with 0.54g of fish oil; F3: with 1.08g of fish oil). The CCC formulations (F1, F2 and F3) were analyzed for fungi, total and thermotolerant coliforms, coagulase-positive staphylococci, and Salmonella sp.; acceptability and sensory preference were also assessed, as well as the centesimal composition, total phenols, antioxidant activity, pH, total titratable acidity and calories. Taste was the most important factor in the choice of the product, being omega 3 (54.28%) and oregano (57.14%) chosen by the majority of the participants. All formulations were microbiologically safe and had the same acceptability and sensory preference. The acceptability index varied from 7.43 to 8.13. The CCC formulations are in conformity with legislation, are low fat (1.77 to 2.66% of lipids), have high moisture (>55%) and low acidity (3.12 to 3.28g of lactic acid/100g), and have an expressive antioxidant activity and marketing potential (acceptability was >70%). The CCCs are viable for incorporation of fish oil, being an omega-3 source product with functional property. (AU)

Lycopene-Rich Extract from Red Guava (Psidium guajava L.) Decreases Plasma Triglycerides and Improves Oxidative Stress Biomarkers on Experimentally-Induced Dyslipidemia in Hamsters.

This work assessed the effects of a 28-day treatment with lycopene-rich extract (LRE) from red guava fruit (Psidium guajava L.) on the lipid profile and oxidative stress in an experimental model of dyslipidemia. Male hamsters (116.5 ± 2.16 g) were fed with the AIN 93G diet containing casein (20%), coconut fat (13.5%) and cholesterol (0.1%). The animals were divided into four groups: normolipidemic control (standard feed; NC, n = 7); hypercholesterolemic control (HC, n = 7); LRE 25 mg/kg/day (LRE-25, n = 7) and LRE 50 mg/kg/day (LRE-50, n = 9). After treatment, plasma concentrations of triglycerides (TG), total cholesterol (TC), low-density lipoprotein (LDL) cholesterol (LDL-c), high-density lipoprotein (HDL) cholesterol (HDL-c), malondialdehyde (MDA-p) and myeloperoxidase (MPO), as well as erythrocytic superoxide dismutase (SOD-e) and the atherogenic index, were determined. Malondialdehyde (MDA-h), catalase (CAT), glutathione peroxidase (GPx) and superoxide dismutase (SOD-h) levels were assessed. Feed intake (FI) and weight gain (WG) were also determined. The LRE-25 group presented significantly lower TG levels and atherogenic index than did the HC group (p < 0.05). Both LRE-25 and LRE-50 groups presented lower levels of MDA-p and MPO than did the HC group (p < 0.05). LRE demonstrated a promising effect against dyslipidemia and oxidative stress.